<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                Part 314: Applications For Fda Approval To Market A New Drug
                            </h3>
                            <table>
  <thead>
    <tr>
      <th scope="col">Section No.</th>
      <th scope="col">Description</th>
    </tr>
  </thead>
  <tbody>
    
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.1.html">
                        Section 314.1
                        </a>
                  </td>
                  <td scope="row">Purpose</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.2.html">
                        Section 314.2
                        </a>
                  </td>
                  <td scope="row">Definitions</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.3.html">
                        Section 314.3
                        </a>
                  </td>
                  <td scope="row">Content and format of an application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.50.html">
                        Section 314.50
                        </a>
                  </td>
                  <td scope="row">Notice of certification of invalidity or noninfringement of a patent</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.52.html">
                        Section 314.52
                        </a>
                  </td>
                  <td scope="row">Submission of patent information</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.53.html">
                        Section 314.53
                        </a>
                  </td>
                  <td scope="row">Procedure for submission of an application requiring investigations for approval of a new indication for, or other change</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.54.html">
                        Section 314.54
                        </a>
                  </td>
                  <td scope="row">Pediatric use information</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.55.html">
                        Section 314.55
                        </a>
                  </td>
                  <td scope="row">Amendments to an unapproved application, supplement, or resubmission</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.60.html">
                        Section 314.60
                        </a>
                  </td>
                  <td scope="row">Withdrawal by the applicant of an unapproved application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.65.html">
                        Section 314.65
                        </a>
                  </td>
                  <td scope="row">Supplements and other changes to an approved application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.70.html">
                        Section 314.70
                        </a>
                  </td>
                  <td scope="row">Procedures for submission of a supplement to an approved application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.71.html">
                        Section 314.71
                        </a>
                  </td>
                  <td scope="row">Change in ownership of an application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.72.html">
                        Section 314.72
                        </a>
                  </td>
                  <td scope="row">Postmarketing reporting of adverse drug experiences</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.80.html">
                        Section 314.80
                        </a>
                  </td>
                  <td scope="row">Postmarketing reporting of adverse drug experiences</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.80.html">
                        Section 314.80
                        </a>
                  </td>
                  <td scope="row">Other postmarketing reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.81.html">
                        Section 314.81
                        </a>
                  </td>
                  <td scope="row">Waivers</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.90.html">
                        Section 314.90
                        </a>
                  </td>
                  <td scope="row">Obtaining a reduction in the discontinuance notification period</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.91.html">
                        Section 314.91
                        </a>
                  </td>
                  <td scope="row">Drug products for which abbreviated applications may be submitted</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.92.html">
                        Section 314.92
                        </a>
                  </td>
                  <td scope="row">Petition to request a change from a listed drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.93.html">
                        Section 314.93
                        </a>
                  </td>
                  <td scope="row">Content and format of an abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.94.html">
                        Section 314.94
                        </a>
                  </td>
                  <td scope="row">Notice of certification of invalidity or noninfringement of a patent</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.95.html">
                        Section 314.95
                        </a>
                  </td>
                  <td scope="row">Amendments to an unapproved abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.96.html">
                        Section 314.96
                        </a>
                  </td>
                  <td scope="row">Supplements and other changes to an approved abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.97.html">
                        Section 314.97
                        </a>
                  </td>
                  <td scope="row">Postmarketing reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.98.html">
                        Section 314.98
                        </a>
                  </td>
                  <td scope="row">Postmarketing reports</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.98.html">
                        Section 314.98
                        </a>
                  </td>
                  <td scope="row">Other responsibilities of an applicant of an abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.99.html">
                        Section 314.99
                        </a>
                  </td>
                  <td scope="row">Timeframes for reviewing applications and abbreviated applications</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.100.html">
                        Section 314.100
                        </a>
                  </td>
                  <td scope="row">Filing an application and receiving an abbreviated new drug application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.101.html">
                        Section 314.101
                        </a>
                  </td>
                  <td scope="row">Communications between FDA and applicants</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.102.html">
                        Section 314.102
                        </a>
                  </td>
                  <td scope="row">Dispute resolution</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.103.html">
                        Section 314.103
                        </a>
                  </td>
                  <td scope="row">Drugs with potential for abuse</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.104.html">
                        Section 314.104
                        </a>
                  </td>
                  <td scope="row">Approval of an application and an abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.105.html">
                        Section 314.105
                        </a>
                  </td>
                  <td scope="row">Foreign data</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.106.html">
                        Section 314.106
                        </a>
                  </td>
                  <td scope="row">Effective date of approval of a 505(b)(2) application or abbreviated new drug application under section 505(j) of the act</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.107.html">
                        Section 314.107
                        </a>
                  </td>
                  <td scope="row">New drug product exclusivity</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.108.html">
                        Section 314.108
                        </a>
                  </td>
                  <td scope="row">Complete response letter to the applicant</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.110.html">
                        Section 314.110
                        </a>
                  </td>
                  <td scope="row">Submitting an abbreviated application for, or a 505(j)(2)(C) petition that relies on, a listed drug that is no</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.122.html">
                        Section 314.122
                        </a>
                  </td>
                  <td scope="row">Refusal to approve an application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.125.html">
                        Section 314.125
                        </a>
                  </td>
                  <td scope="row">Adequate and well-controlled studies</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.126.html">
                        Section 314.126
                        </a>
                  </td>
                  <td scope="row">Refusal to approve an abbreviated new drug application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.127.html">
                        Section 314.127
                        </a>
                  </td>
                  <td scope="row">Withdrawal of approval of an application or abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.150.html">
                        Section 314.150
                        </a>
                  </td>
                  <td scope="row">Withdrawal of approval of an abbreviated new drug application under section 505(j)(5) of the act</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.151.html">
                        Section 314.151
                        </a>
                  </td>
                  <td scope="row">Notice of withdrawal of approval of an application or abbreviated application for a new drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.152.html">
                        Section 314.152
                        </a>
                  </td>
                  <td scope="row">Suspension of approval of an abbreviated new drug application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.153.html">
                        Section 314.153
                        </a>
                  </td>
                  <td scope="row">Approval of an application or abbreviated application for which approval was previously refused, suspended, or withdrawn</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.160.html">
                        Section 314.160
                        </a>
                  </td>
                  <td scope="row">Determination of reasons for voluntary withdrawal of a listed drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.161.html">
                        Section 314.161
                        </a>
                  </td>
                  <td scope="row">Removal of a drug product from the list</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.162.html">
                        Section 314.162
                        </a>
                  </td>
                  <td scope="row">Adulteration and misbranding of an approved drug</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.170.html">
                        Section 314.170
                        </a>
                  </td>
                  <td scope="row">Notice of opportunity for hearing; notice of participation and request for hearing; grant or denial of hearing</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.200.html">
                        Section 314.200
                        </a>
                  </td>
                  <td scope="row">Procedure for hearings</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.201.html">
                        Section 314.201
                        </a>
                  </td>
                  <td scope="row">Judicial review</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.235.html">
                        Section 314.235
                        </a>
                  </td>
                  <td scope="row">Imports and exports of new drugs</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.410.html">
                        Section 314.410
                        </a>
                  </td>
                  <td scope="row">Drug master files</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.420.html">
                        Section 314.420
                        </a>
                  </td>
                  <td scope="row">Availability for public disclosure of data and information in an application or abbreviated application</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.430.html">
                        Section 314.430
                        </a>
                  </td>
                  <td scope="row">Addresses for applications and abbreviated applications</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.440.html">
                        Section 314.440
                        </a>
                  </td>
                  <td scope="row">Guidance documents</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.445.html">
                        Section 314.445
                        </a>
                  </td>
                  <td scope="row">Scope</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.500.html">
                        Section 314.500
                        </a>
                  </td>
                  <td scope="row">Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.510.html">
                        Section 314.510
                        </a>
                  </td>
                  <td scope="row">Approval with restrictions to assure safe use</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.520.html">
                        Section 314.520
                        </a>
                  </td>
                  <td scope="row">Withdrawal procedures</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.530.html">
                        Section 314.530
                        </a>
                  </td>
                  <td scope="row">Postmarketing safety reporting</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.540.html">
                        Section 314.540
                        </a>
                  </td>
                  <td scope="row">Promotional materials</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.550.html">
                        Section 314.550
                        </a>
                  </td>
                  <td scope="row">Termination of requirements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.560.html">
                        Section 314.560
                        </a>
                  </td>
                  <td scope="row">Scope</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.600.html">
                        Section 314.600
                        </a>
                  </td>
                  <td scope="row">Approval based on evidence of effectiveness from studies in animals</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.610.html">
                        Section 314.610
                        </a>
                  </td>
                  <td scope="row">Withdrawal procedures</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.620.html">
                        Section 314.620
                        </a>
                  </td>
                  <td scope="row">Postmarketing safety reporting</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.630.html">
                        Section 314.630
                        </a>
                  </td>
                  <td scope="row">Promotional materials</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.640.html">
                        Section 314.640
                        </a>
                  </td>
                  <td scope="row">Termination of requirements</td>
                </tr>
                
                <tr>
                  <td scope="row"><a href="/html/sections/21CFR314.650.html">
                        Section 314.650
                        </a>
                  </td>
                  <td scope="row">Scope</td>
                </tr>
                
  </tbody>
</table>

      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
